tiprankstipranks
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market

CSPC Pharmaceutical Group (CHJTF) Financial Statements

Compare
21 Followers

CSPC Pharmaceutical Group Financial Overview

CSPC Pharmaceutical Group's market cap is currently $7.28B. The company's EPS TTM is $0.069; its P/E ratio is 9.34; and it has a dividend yield of 6.17%. CSPC Pharmaceutical Group is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 34.60B¥ 31.59B¥ 33.59B¥ 28.03B¥ 25.06B
Gross Profit¥ 24.40B¥ 22.73B¥ 25.47B¥ 21.00B¥ 18.04B
Operating Income¥ 7.68B¥ 6.93B¥ 7.53B¥ 6.11B¥ 5.05B
EBITDA¥ 8.53B¥ 7.60B¥ 9.28B¥ 8.09B¥ 5.35B
Net Income¥ 5.87B¥ 5.35B¥ 5.61B¥ 5.16B¥ 4.21B
Balance Sheet
Cash & Short-Term Investments¥ 13.09B¥ 13.68B¥ 13.12B¥ 10.47B¥ 6.87B
Total Assets¥ 46.28B¥ 41.18B¥ 42.50B¥ 35.65B¥ 29.44B
Total Debt¥ 706.90M¥ 574.32M¥ 115.04M¥ 375.51M¥ 209.78M
Net Debt¥ -11.31B¥ -9.58B¥ -11.24B¥ -8.27B¥ -4.61B
Total Liabilities¥ 11.26B¥ 9.72B¥ 9.37B¥ 7.96B¥ 7.43B
Stockholders' Equity¥ 30.07B¥ 29.77B¥ 31.79B¥ 26.48B¥ 20.65B
Cash Flow
Free Cash Flow¥ 2.29B¥ 5.32B¥ 3.74B¥ 5.91B¥ 1.99B
Operating Cash Flow¥ 4.18B¥ 8.10B¥ 5.86B¥ 7.67B¥ 4.39B
Investing Cash Flow¥ 607.27M¥ -7.19B¥ -1.06B¥ -2.60B¥ -2.87B
Financing Cash Flow¥ -2.30B¥ -1.95B¥ -2.65B¥ -1.65B¥ -1.77B
Currency in CNY

CSPC Pharmaceutical Group Earnings and Revenue History

CSPC Pharmaceutical Group Debt to Assets

CSPC Pharmaceutical Group Cash Flow

CSPC Pharmaceutical Group Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis